Wolff–Parkinson–White syndrome: Difference between revisions
Line 33: | Line 33: | ||
*Antidromic | *Antidromic | ||
** | **Treat like ventricular tachycardia | ||
***Contraindicated: CCBs, BBs, digoxin, adenosine | ***Contraindicated: CCBs, BBs, digoxin, adenosine | ||
**Cardioversion (synchronized) | **Cardioversion (synchronized) |
Revision as of 04:53, 26 March 2012
Background
- Orthodromic (~95%)
- Accessory pathway (Kent bundles) is used for retrograde reentry conduction
- QRS narrow (delta wave absent)
- May see ST depression, TWI
- Rate 150-250 bpm
- Accessory pathway (Kent bundles) is used for retrograde reentry conduction
- Antidromic (~5%)
- Accessory pathway used for anterograde conduction
- QRS wide, delta wave present
- Accessory pathway used for anterograde conduction
- Atrial fibrillation seen in 10-30%
- Ventricular rate >300 suggests preexcitation
Diagnosis
- Characteristic features not always seen on ECG
- Short PR interval - <0.12sec
- Due to loss of normal AV node conduction delay
- Delta wave / slurred upstroke
- Due to early activation of ventricular myocardium
- QRS duration > 0.10 sec
- Due to delta wave
Treatment
- Orthodromic
- Treat like paroxysmal SVT
- CCBs, BBs, procainamide, or adenosine
- Procainamide safe irrespective of type of pathway conduction
- Cardiovert (sync) if unstable
- Adult: 50-100 J
- Peds: 0.5- 2 J/kg
- Treat like paroxysmal SVT
- Antidromic
- Treat like ventricular tachycardia
- Contraindicated: CCBs, BBs, digoxin, adenosine
- Cardioversion (synchronized)
- Adult: 50-100 J
- Peds: 0.5- 2 J/kg
- Procainamide 100mg q10min until dysrhythmia terminated or max dose (1000mg)
- Amiodarone
- Treat like ventricular tachycardia
- Irregular tachycardia
- Treat like antidromic
Disposition
- Admit:
- Pts with chest pain, CHF, electrolyte imbalance, or required cardioversion
- Discharge:
- Consider if dysrhythmia was easily terminated and can arrange outpt EP study